Green Cross Lab Cell Corporation (144510) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.67 Billion ≈ $4.52 Million USD) by net assets (₩431.56 Billion ≈ $292.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 144510 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Green Cross Lab Cell Corporation - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Green Cross Lab Cell Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Green Cross Lab Cell Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross Lab Cell Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Berjaya Assets Bhd KLSE:3239	0.032x
Talisker Resources Ltd TO:TSK	-0.381x
Fks Multi Agro Tbk JK:FISH	-0.011x
Lotte Chemical Titan Holding BHD KLSE:5284	-0.011x
ChargePoint Holdings Inc NYSE:CHPT	4.017x
Lanson BCC SA PA:ALLAN	0.016x
Eaton Vance New York MBF NYSE MKT:ENX	0.037x
Nkarta Inc NASDAQ:NKTX	-0.099x

Annual Cash Flow Conversion Efficiency for Green Cross Lab Cell Corporation (2015–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross Lab Cell Corporation from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross Lab Cell Corporation market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩457.79 Billion ≈ $310.24 Million	₩11.34 Billion ≈ $7.69 Million	0.025x	+265.48%
2023-12-31	₩541.48 Billion ≈ $366.95 Million	₩3.67 Billion ≈ $2.49 Million	0.007x	-94.50%
2022-12-31	₩538.46 Billion ≈ $364.91 Million	₩66.42 Billion ≈ $45.01 Million	0.123x	+163.63%
2021-12-31	₩511.00 Billion ≈ $346.30 Million	₩23.91 Billion ≈ $16.20 Million	0.047x	-75.73%
2020-12-31	₩47.17 Billion ≈ $31.97 Million	₩9.09 Billion ≈ $6.16 Million	0.193x	+3707.58%
2019-12-31	₩44.05 Billion ≈ $29.85 Million	₩223.04 Million ≈ $151.15K	0.005x	-50.78%
2018-12-31	₩47.72 Billion ≈ $32.34 Million	₩490.92 Million ≈ $332.69K	0.010x	-82.63%
2017-12-31	₩48.32 Billion ≈ $32.75 Million	₩2.86 Billion ≈ $1.94 Million	0.059x	+1059.97%
2016-12-31	₩48.10 Billion ≈ $32.59 Million	₩-296.65 Million ≈ $-201.04K	-0.006x	-103.71%
2015-12-31	₩8.96 Billion ≈ $6.07 Million	₩1.49 Billion ≈ $1.01 Million	0.166x	--

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$179.74 Million

₩265.23 Billion KRW

Market Cap Rank

#17071 Global

#675 in Korea

Share Price

₩17650.00

Change (1 day)

-2.86%

52-Week Range

₩15710.00 - ₩27500.00

All Time High

₩126167.70